EU patent changes may spur stem cell research
Human embryonic stem cell research could help combat diseases more effectively, but legal challenges inhibit research
You must be signed in to read this analysis
In this article
- EU ban on patenting human ES cells
- Effect on research funding
- Ruling challenge
- Outlook
What is this?
This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.
_350.jpg "A researcher controls medium for culturing stem cells (Reuters/Jo Yong-Hak)")